Intrinsic Value
Avalo Therapeutics, Inc. (AVTX)
$21.75
+17.00 (+357.89%)
Enterprise Value | -5,125.11 |
---|---|
Net Debt | 6.24 |
Equity Value | -5,131.36 |
Shares Outstanding | 9.41 |
Equity Value Per Share | -545.40 |
Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt